CRH Medical Corporation is a medical instruments & supplies business based in the US. CRH Medical Corporation shares (CRHM) are listed on the NYSE MKT and all prices are listed in US Dollars. CRH Medical Corporation employs 133 staff and has a trailing 12-month revenue of around $106.2 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| 52-week range | $0.00 - $0.00 |
|---|---|
| 50-day moving average | $3.96 |
| 200-day moving average | $3.00 |
| Wall St. target price | $3.40 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $0.02 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing CRH Medical Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CRH Medical Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CRH Medical Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $34.2 million.
The EBITDA is a measure of a CRH Medical Corporation's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $106.2 million |
|---|---|
| Gross profit TTM | $2.2 million |
| Return on assets TTM | -2.06% |
| Return on equity TTM | -19.91% |
| Profit margin | -23.05% |
| Book value | $0.75 |
| Market Capitalization | $282.2 million |
TTM: trailing 12 months
We're not expecting CRH Medical Corporation to pay a dividend over the next 12 months.
Over the last 12 months, CRH Medical Corporation's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while CRH Medical Corporation's is 3.1102. This would suggest that CRH Medical Corporation's shares are significantly more volatile than the average for this exchange and represent a higher risk.
CRH Medical Corporation provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology to treat various grades of hemorrhoid. The company distributes CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to gastroenterology practices. It also offers a hemorrhoid banding ancillary program, cybersecurity, and a consumer-centric digital application. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was founded in 2000 and is headquartered in Vancouver, Canada.
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
These are the stocks to buy when you don’t have much to spend.
Explore the best bonuses for opening a new brokerage account.
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
What you need to know about investing in the leading indicator for the overall US stock market.
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Read our beginner’s guide to trading options in the US.